Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,019 total articles
Director Wu Lei, together with entities Shan Lao Hu Tong LLC and Ji Xiang Hu Tong Holdings LTD, sold 58,990 Class A Ordinary Shares of GigaCloud Technology Inc (NASDAQ: GCT) for about $2.45 million between March 19 and March 20, 2026. The transactions were made under a 10b5-1 trading plan adopted September 24, 2025, which has now concluded. Separat…
Kenneth S. Courtis, a director at Alpha Metallurgical Resources, Inc. (NASDAQ: AMR), executed a series of open-market purchases on March 12, 2026, acquiring company shares totaling $1.53 million at prices between $187.47 and $193.94. The transactions increased Courtis's direct stake in the coal miner to 874,537 shares. The trades occur against the …
Indie Semiconductor's President Ichiro Aoki sold 150,000 shares of Class A common stock between March 18 and March 20, 2026, realizing approximately $388,125. The transactions were carried out under a Rule 10b5-1 plan and coincided with share-price weakness and a number of corporate developments, including a $150 million convertible senior note off…
NVIDIA Executive Vice President and Chief Financial Officer Colette Kress completed a $10.9 million sale of company stock on March 20, 2026, disposing of 68,798 shares at prices between $171.9681 and $177.5122. Two days earlier she sold 76,535 shares at $181.93 to satisfy tax obligations. Following these transactions she directly holds 881,387 shar…
Aarti S. Shah, a member of Nvidia's board, sold 19,000 shares of company stock on March 19, 2026, in three transactions that totaled $3.36 million. The trades were carried out under a Rule 10b5-1 plan adopted in November 2024. The filing, signed March 20, 2026, shows Shah retains 36,007 shares after the sales. The move comes amid mixed price perfor…
Nvidia Executive Vice President Ajay K. Puri sold 299,970 shares of the company's common stock on March 18, 2026, in multiple transactions totaling roughly $54.7 million. On the same date he also sold 69,529 shares to meet tax obligations tied to vesting restricted stock units, a transaction valued at $12.6 million. The shares traded in a range fro…
A Delek US Holdings director, Yemin Ezra Uzi, executed four stock sales on March 18, 2026 under a pre-arranged 10b5-1 trading plan, selling a combined 55,156 shares for roughly $2.43 million. The transactions come while the company's stock is trading close to its 52-week high following a strong 12-month rally, and after the release of fourth-quarte…
A Delek US Holdings director sold 5,000 shares on March 18, 2026, for $45.50 per share, totaling $227,500. The transaction occurred as the stock neared its 52-week high of $46.80 after a 172% gain over the past year. The seller now holds 41,369 shares. The sale was carried out under a pre-arranged 10b5-1 trading plan. Separately, the company report…
Nvidia principal accounting officer Donald F. Robertson Jr. reported multiple stock dispositions in mid-March 2026, including 4,596 shares sold on March 20 for about $942,944 and a separate 4,575-share sale on March 18 to cover taxes valued at $832,329. After these moves Robertson retains direct ownership of 337,120 Nvidia shares. The sales occur a…
Regina A. Tobin, President of Texas Roadhouse Inc, filed a Form 4 disclosing the sale of 4,450 shares on March 19, 2026, for $171.00 apiece, totaling $760,950. The transaction leaves Tobin with 13,778 directly held shares and outstanding restricted stock units vesting in 2027 and 2028. The sale comes after a fourth-quarter 2025 earnings shortfall d…
AppLovin Corp director Eduardo Vivas sold 20,910 shares of Class A common stock on March 13, 2026, at $458.67 per share for approximately $9.5 million. The transaction left Vivas with direct ownership of 7,112,382.249 shares, some of which are represented by restricted stock units, and included a transfer of shares into an exchange-traded fund wher…
Snowflake Inc. director Frank Slootman executed planned stock sales totaling 99,999 shares on March 18 and 19, 2026, generating about $17.5 million. The trades, carried out under a 10b5-1 plan adopted September 19, 2025, coincided with option exercises and follow a year-to-date stock decline of 23.4%, even as the company reported notable revenue gr…
Rui Avelar, an officer at Evolus, Inc. (NASDAQ: EOLS), sold 3,119 shares of common stock on March 20, 2026, in transactions conducted under a pre-established Rule 10b5-1 trading plan to satisfy tax-withholding obligations tied to restricted stock unit settlements. The trades totaled $14,815 at a weighted average price of $4.75 as the stock sits nea…
Evolus President and Chief Executive Officer David Moatazedi sold 13,669 shares on March 20, 2026 under a Rule 10b5-1 plan to satisfy tax withholding tied to restricted stock units, receiving approximately $64,929. The company recently reported fourth-quarter 2025 revenue of $90.3 million, narrowly missing expectations, and moved to rebalance board…
Ekso Bionics Holdings COO Jason C. Jones acquired 1,308 shares on March 16, 2026, through a 401(k) account for $15,499. The transaction comes as the company pursues a private placement and a proposed merger with Applied Digital Cloud to form ChronoScale Corporation; the deal has prompted an analyst downgrade and raises questions about dilution and …
Michael C. Bucella, a director at Terawulf Inc. (NASDAQ: WULF), purchased 1,665 shares on March 20, 2026, spending $25,041 and bringing his direct stake to 280,052 shares. The move comes amid the company closing a $500 million bridge loan for its Hawesville, Kentucky data center and a series of analyst price-target adjustments tied to Terawulf's fo…
Ekso Bionics Chief Financial Officer Jerome Wong acquired 1,308 shares of company stock on March 16, 2026, through the firm’s 401(k) contribution matching program. The purchase, executed at $11.85 per share for $15,499, comes as the shares trade at $10.54 and recent corporate moves include a roughly $5.9 million private placement and a non-binding …
Reddit Chief Operating Officer Jennifer L. Wong sold $5.6 million worth of Class A Common Stock on March 18, 2026, across multiple transactions and exercised options to acquire 33,507 shares at $5.35 per share. The sales were conducted under a Rule 10b5-1 trading plan adopted in May 2025. After the transactions, Wong directly holds 1,088,451 shares…
Bob Matthew Regis, a director at APA Corp, sold 23,000 shares on March 18, 2026, for $833,372 at weighted average prices between $36.21 and $36.285. The stock is trading near a 52-week high after roughly a 100% gain over the past year. APA’s Q4 2025 results showed an EPS beat of $0.91 versus a $0.73 forecast, while revenue of $1.98 billion missed a…
Hershey Trust Co., acting as trustee for the Milton Hershey School, disposed of 27,070 shares of Hershey Co. (HSY) common stock between March 18 and March 20, 2026, netting $6.3 million. The sales were executed at prices between $209.5141 and $217.1248. Despite the transaction, the trust maintains a significant ownership stake in Hershey through di…
Control Empresarial de Capitales S.A. de C.V., a roughly 10% holder of PBF Energy Inc., disposed of 1,158,000 Class A shares in multiple trades on March 18-19, 2026, raising about $53.4 million. The sales took place as PBF shares traded close to a 52-week peak and after the company reported fourth-quarter 2025 results that beat adjusted EPS expecta…
Maze Therapeutics President of R&D and CMO Harold Bernstein sold 15,000 shares on March 20, 2026, in transactions totaling $736,439 after exercising options to acquire 15,000 shares at $10.42. The company has drawn positive analyst attention even as its shares trade well above fair value estimates and prepare to report earnings on April 6, 2026.
Kelli Keough, Executive Vice President at SoFi Technologies (SOFI), executed a planned sale of 9,742 shares on March 20, 2026, generating roughly $165,066. The trades, carried out under a Rule 10b5-1 plan adopted last July, spanned prices of $16.70 to $17.36 per share. The transaction occurred amid a flurry of company developments including a Maste…
Kymera Therapeutics director Pamela Esposito completed a set of transactions on March 20, 2026, selling 2,500 shares for $197,877 while exercising options to acquire 2,500 shares at $49.10. The activity comes as analysts raise price targets following the company's fourth-quarter and full-year 2025 results and ahead of a planned KT-621 data presenta…
Heartflow Chief Executive Officer John C.M. Farquhar sold 9,725 shares at $25.00 on March 18, 2026, under a pre-arranged Rule 10b5-1 plan, generating proceeds of $243,125 and leaving him with 571,725 shares. The transaction was reported in a Form 4 filed with the SEC and was signed by Nga Van by power of attorney on March 20, 2026. The stock has ri…
